DK192583A - Phenylalaninderivater og deres anvendelse til fremme af laegemiddelabsorption - Google Patents

Phenylalaninderivater og deres anvendelse til fremme af laegemiddelabsorption Download PDF

Info

Publication number
DK192583A
DK192583A DK192583A DK192583A DK192583A DK 192583 A DK192583 A DK 192583A DK 192583 A DK192583 A DK 192583A DK 192583 A DK192583 A DK 192583A DK 192583 A DK192583 A DK 192583A
Authority
DK
Denmark
Prior art keywords
promotion
phenylalanine derivatives
pharmaceutical laboratory
laboratory
pharmaceutical
Prior art date
Application number
DK192583A
Other languages
English (en)
Other versions
DK192583D0 (da
DK170855B1 (da
Inventor
Shigeshi Toyoshima
Yoshiko Seto
Koji Fukushima
Izumi Kumashiro
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57073306A external-priority patent/JPS58189121A/ja
Priority claimed from JP6599983A external-priority patent/JPS59190926A/ja
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of DK192583D0 publication Critical patent/DK192583D0/da
Publication of DK192583A publication Critical patent/DK192583A/da
Application granted granted Critical
Publication of DK170855B1 publication Critical patent/DK170855B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK192583A 1982-04-30 1983-04-28 Phenylalaninderivater DK170855B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP7330682 1982-04-30
JP57073306A JPS58189121A (ja) 1982-04-30 1982-04-30 インシユリン投与賦活剤
JP6599983 1983-04-14
JP6599983A JPS59190926A (ja) 1983-04-14 1983-04-14 吸収性付与剤

Publications (3)

Publication Number Publication Date
DK192583D0 DK192583D0 (da) 1983-04-28
DK192583A true DK192583A (da) 1983-10-31
DK170855B1 DK170855B1 (da) 1996-02-12

Family

ID=26407159

Family Applications (1)

Application Number Title Priority Date Filing Date
DK192583A DK170855B1 (da) 1982-04-30 1983-04-28 Phenylalaninderivater

Country Status (5)

Country Link
US (1) US4670584A (da)
EP (1) EP0093551B1 (da)
CA (1) CA1250090A (da)
DE (1) DE3382112D1 (da)
DK (1) DK170855B1 (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053389A (en) * 1986-04-18 1991-10-01 Per Balschmidt Insulin preparation for non-parenteral administration

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
DE3674474D1 (de) * 1985-06-08 1990-10-31 Suntory Ltd Phenoxyacetylamidderivate, verfahren zu ihrer herstellung und ihre verwendung.
JPH0791251B2 (ja) * 1987-11-20 1995-10-04 味の素株式会社 フェニルアラニン誘導体及びその用途
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US20020042377A1 (en) * 1995-06-07 2002-04-11 Steiner Joseph P. Rotamase enzyme activity inhibitors
CN1261449C (zh) * 1999-04-26 2006-06-28 味之素株式会社 促黑素细胞激素抑制剂
US6878749B2 (en) * 1999-09-17 2005-04-12 Novartis Ag Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
EP1265638A1 (en) * 1999-11-12 2002-12-18 Pharmaderm Laboratories Ltd. Compositions for transdermal and transmucosal administration of therapeutic agents
DK1334962T3 (da) 2000-10-18 2007-12-10 Ajinomoto Kk Fremgangsmåder til fremstilling af acylphenylalanin
FR2828102B1 (fr) * 2001-03-28 2004-07-09 Ifc Sa Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteur et systeme disperse a usage pharmaceutique contenant de tels composes
GB2389582A (en) * 2002-06-13 2003-12-17 Bayer Ag Pharmaceutically active carboxamides
EP2919804B1 (fr) 2012-11-13 2018-01-31 Adocia Formulation à action rapide d'insuline comprenant un composé anionique substitué
US9795678B2 (en) * 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3020947B1 (fr) * 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
FR3043557B1 (fr) * 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
WO2017084696A1 (fr) * 2015-11-16 2017-05-26 Adocia Composition a action rapide d'insuline comprenant un compose anionique substitue et un compose polyanionique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5123056B2 (da) * 1972-04-03 1976-07-14
IL46207A0 (en) * 1974-12-09 1975-03-13 Technion Res & Dev Foundation Process for the direct manufacture of acyl derivatives of aromatic alpha-amino acids
DE3003898A1 (de) * 1980-02-02 1981-08-13 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur acylierung von aminocarbonsaeuren
FR2509175B1 (fr) * 1981-03-06 1987-01-16 Toyo Jozo Kk Preparation therapeutique ayant d'excellentes proprietes d'absorption

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053389A (en) * 1986-04-18 1991-10-01 Per Balschmidt Insulin preparation for non-parenteral administration

Also Published As

Publication number Publication date
DK192583D0 (da) 1983-04-28
US4670584A (en) 1987-06-02
CA1250090A (en) 1989-02-14
DK170855B1 (da) 1996-02-12
EP0093551A3 (en) 1985-11-21
EP0093551B1 (en) 1991-01-16
DE3382112D1 (de) 1991-02-21
EP0093551A2 (en) 1983-11-09

Similar Documents

Publication Publication Date Title
DK195587A (da) Phenylpiperazinderivater og deres anvendelse til fremstilling af antiarrytmi-laegemidler
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK192583D0 (da) Phenylalaninderivater og deres anvendelse til fremme af laegemiddelabsorption
DK33287D0 (da) Imidazolanaloge af mevalonolacton og derivater deraf
DK561881A (da) Farmaceutiske phenolether-forbindelser og mellemprodukter for disse samt fremgangsmaade til deres fremstilling
DK163640C (da) Apparat til administrering af medikamenter
DK559586D0 (da) Fremgangsmaade til direkte indfaering af dna i plastider og mitochondrier
DK184783D0 (da) Hidtil ukendte derivater af aren og heteroaren carboxamider og deres anvendelse som laegemidler
DK158269C (da) Analogifremgangsmaade til fremstilling af morpholinyldaunorubicin- eller morpholinyldoxorubicinderivater
DK237187A (da) Farmaceutisk anvendelse af t-pa
DK32383D0 (da) Phosphinsyrederivater og fremgangsmade til fremstilling af disse
DK226488D0 (da) Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
DK350883D0 (da) Fremgangsmade til fremstilling af mycaminosyltylonolid og beslaegtede macrolidderivater og mellemprodukter herved
DK189386D0 (da) Fremgangsmaade til fremstilling af betonblandinger og flydende blandingdertil
DK522888D0 (da) Heterocykliske derivater og farmaceutiske praeparater med indhold af saadanne
DK289585A (da) Arylderivater af heterobicycliske forbindelser, deres farmaceutiske anvendelse og deres fremstilling
DK38493D0 (da) Fremgangsmaade til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
DK556483A (da) Benzofuranylderivater og deres fremstilling
DK423284A (da) Naphthalenylimidazopyridin og derivater heraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK593986A (da) Forbindelser og farmaceutiske praeparater til inhibering af 5-lipoxygenase-vejen
DK440281A (da) Fremgangsmaade til fremstilling af n-carboxylalkyldipeptider og derivater deraf
DK101481A (da) Hidtil ukendte derivater af 3-chlorquinolin fremgangsmaader til deres fremstilling og deres anvendelse som laegemidler
DK701588D0 (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK489084D0 (da) Fremgangsmaade til udvinding af beta-elemonsyre og farmaceutisk praeparat indeholdende beta-elemonsyre
DK163994C (da) 1-phenoxy-2-hydroxy-3-aminopropanderivater, farmaceutisk praeparat indeholdende derivaterne og anvendelse af derivaterne

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed